Search
Imgatuzumab
go.drugbank.com/drugs/DB14884InvestigationalImgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With
Alobresib
go.drugbank.com/drugs/DB14970InvestigationalAlobresib is under investigation in clinical trial NCT02607228 (Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 as a Single Agent and In Combination With Enzalutamide in Participants
Rocapuldencel-T
go.drugbank.com/drugs/DB17588InvestigationalRocapuldencel-T is an autologous dendritic cell immunotherapy that was investigated in NCT02662634 (A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer
AVXS-301
go.drugbank.com/drugs/DB17943ExperimentalAVXS-301 consists of an adeno-associated virus serotype 9 (AAV9) designed to express the superoxide dismutase 1 (SOD1) gene.
beta-Naphthoflavone
go.drugbank.com/drugs/DB06732Experimentalβ-Naphthoflavone, also known as 5,6-benzoflavone, is a potent agonist of the aryl hydrocarbon receptor and induces cytochromes P450 (CYPs) and uridine 5'-diphospho-glucuronosyltransferases (UGTs). … It may be a chemopreventive agent.
(+)-Mefloquine
go.drugbank.com/drugs/DB05636Investigational(+)-Mefloquine was under investigation in clinical trial NCT00931697 (Study to Investigate the Safety, Tolerability and Pharmacokinetics of AD 452 [(+)-Mefloquine] Compared With Racemic Mefloquine) to
Canertinib
go.drugbank.com/drugs/DB05424InvestigationalCanertinib treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET. … Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo.
Categories: Compounds used in a research, industrial, or household settingBenclonidine
go.drugbank.com/drugs/DB19610ExperimentalBenclonidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Benclonidine is a a2 adrenoreceptor agonist. … Benclonidine has a monoisotopic molecular weight of 333.04 Da.
Flutonidine
go.drugbank.com/drugs/DB21438ExperimentalFlutonidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Flutonidine is a a2 adrenoreceptor agonist. … Flutonidine has a monoisotopic molecular weight of 193.1 Da.
Povafonidine
go.drugbank.com/drugs/DB21470ExperimentalPovafonidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Povafonidine is a a2 adrenoreceptor agonist. … Povafonidine has a monoisotopic molecular weight of 215.12 Da.